At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MGRX Mangoceuticals, Inc.
Market Closed 12-12 16:00:00 EST
1.13
+0.00
0.00%
盘后1.18
+0.05+4.29%
19:44 EST
High1.15Low1.09Vol185.17K
Open1.13D1 Closing1.13Amplitude5.31%
Mkt Cap15.71MTradable Cap8.54MTotal Shares13.91M
T/O208.44KT/O Rate2.45%Tradable Shares7.55M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
Reuters  ·  12-10
CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares
Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares
Reuters  ·  11-27
Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares
U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly
Stock News  ·  11-14
U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly
BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk
Reuters  ·  11-14
BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk
Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk
THOMSON REUTERS  ·  11-14
Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk
Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications
THOMSON REUTERS  ·  11-14
Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications
BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA
Reuters  ·  11-14
BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA
Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships
THOMSON REUTERS  ·  11-14
Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships
Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform
MT Newswires Live  ·  11-13
Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform
Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs
THOMSON REUTERS  ·  11-13
Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
Reuters  ·  11-13
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
THOMSON REUTERS  ·  11-13
Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
Mangoceuticals Inc - Launches Mangorx Direct and Peachesrx Direct Programs
THOMSON REUTERS  ·  11-13
Mangoceuticals Inc - Launches Mangorx Direct and Peachesrx Direct Programs
Mangoceuticals Inc. Announces New Compensation Plan Granting CEO Jacob D. Cohen 500,000 Shares and Options for 2 Million More
Reuters  ·  09-13
Mangoceuticals Inc. Announces New Compensation Plan Granting CEO Jacob D. Cohen 500,000 Shares and Options for 2 Million More
Mangoceuticals Inc. Secures $1.1M Through Sale of 709,677 Shares to Accredited Investors
Reuters  ·  09-03
Mangoceuticals Inc. Secures $1.1M Through Sale of 709,677 Shares to Accredited Investors
Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY
Benzinga  ·  08-15
Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY
BRIEF-Mangoceuticals Inc - On July 30, Co Terminates Agreement With Navy Wharf - SEC Filing
Reuters  ·  08-04
BRIEF-Mangoceuticals Inc - On July 30, Co Terminates Agreement With Navy Wharf - SEC Filing
Mangoceuticals Inc - Navy Wharf Cancels All Navy Shares - SEC Filing
THOMSON REUTERS  ·  08-04
Mangoceuticals Inc - Navy Wharf Cancels All Navy Shares - SEC Filing
Mangoceuticals Inc. Announces Issuance of 198,000 Shares from Warrant Exercise and Cancellation of 1,000,000 Shares in Rescission Agreement with Navy Wharf
Reuters  ·  08-04
Mangoceuticals Inc. Announces Issuance of 198,000 Shares from Warrant Exercise and Cancellation of 1,000,000 Shares in Rescission Agreement with Navy Wharf
Mangoceuticals Inc. Amends Bylaws to Establish Series B Preferred Stock
Reuters  ·  07-10
Mangoceuticals Inc. Amends Bylaws to Establish Series B Preferred Stock

Introduction

Company Name.
Mangoceuticals, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Issue price:
--